Source: Virtual Congress 2021 – Acute paediatric respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Z. Nesterenko (St. Petersburg, Russian Federation), N. Prokopeva (St. Petersburg, Russian Federation). Community-acquired pneumonia in COVID-19 positive children: monitoring the clinical course. 1955

Member's Comments

No comment yet.

Related content which might interest you: Community-acquired pneumonia in outpatients: aetiology and outcomes}, Source: Eur Respir J 2012; 40: 931-938 Year: 2012 Community-acquired pneumonia in younger patients is an entity on its own Source: Eur Respir J 2012; 39: 1156-1161 Year: 2012 Community-acquired pneumonia Source: Respipedia Article Year: 2017 Community-acquired pneumonia (CAP) caused by mycoplasma pneumoniae or chlamydophila pneumoniae in children: Are there reliable signs/symptoms for clinical diagnostics? Source: Annual Congress 2013 –The burden of respiratory infections in children Year: 2013 Severe community-acquired pneumonia in China: epidemiology and clinical practice Source: International Congress 2019 – Chinese programme 2019: Part II Year: 2019 Community-acquired pneumonia in children Source: Annual Congress 2012 - PG15 Common respiratory infections in childhood: current guidelines and controversies Year: 2012 Validation of a predictive rule for the management of community-acquired pneumonia Source: Eur Respir J 2006; 27: 151-157 Year: 2006 Etiology and clinical outcome of community-acquired pneumonias in hospitalized children Source: Eur Respir J 2007; 30: Suppl. 51, 398s Year: 2007 Community-acquired pneumonia (CAP): evaluation of severity criteria for hospitalization Source: Eur Respir J 2003; 22: Suppl. 45, 335s Year: 2003 Mixed community-acquired pneumonia in hospitalised patients Source: Eur Respir J 2006; 27: 795-800 Year: 2006 The tobacco-smoking influence on the community-acquired pneumonia course Source: Eur Respir J 2006; 28: Suppl. 50, 247s Year: 2006 PATS and ERS paediatric webinar: reducing the burden of CAP Source: ERS webinar 2021: PATS and ERS paediatric webinar: reducing the burden of CAP Year: 2021 Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study Source: ERJ Open Res, 4 (4) 00096-2018; 10.1183/23120541.00096-2018 Year: 2018 Community-acquired pneumonia in pediatric patients: New diagnostic priorities Source: Annual Congress 2012 - Asthma management Year: 2012 Community-acquired pneumonia: severity and antibiotic treatments Source: ERS Course 2018 - Respiratory Infections Year: 2018 Community-acquired pneumonia: impact of COPD Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know? Year: 2008 Steroids are not associated with an improvement in clinical outcomes in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections Year: 2009 Biomarkers and clinical stability in community-acquired pneumonia Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 Community-acquired pneumonia in the elderly Source: Eur Respir Mon; 2009: 43: 111–132 Year: 2009